ERS 2021: Tezepelumab Offers Benefit for Severe, Uncontrolled Asthma Regardless of Nasal Polyps
Findings help broaden the appropriate patient population for this treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.